S100B and response to treatment in major depression: a pilot study.
about
Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissueRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersAltered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attentionThe S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: biomarkers for nervous system injury.Blood levels of S-100 calcium-binding protein B, high-sensitivity C-reactive protein, and interleukin-6 for changes in depressive symptom severity after coronary artery bypass grafting: prospective cohort nested within a randomized, controlled trialS100B and homocysteine in the acute alcohol withdrawal syndrome.Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptorS100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.Serum S100B represents a new biomarker for mood disorders.Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.Mood disorders are glial disorders: evidence from in vivo studies.Blood-brain barrier dysfunction in brain diseases: clinical experience.Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.Functional assessment of a promoter polymorphism in S100B, a putative risk variant for bipolar disorder.Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model.Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression.Neuron specific enolase and serum remain unaffected by ultra high frequency left prefrontal transcranial magnetic stimulation in patients with depression: a preliminary study.S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.
P2860
Q26827833-1BEBAD7E-BCD6-464B-A43F-792E54B8F384Q27023402-0DE3749D-700B-4C96-9680-4B6471A237BCQ33553152-BE28AB5F-D253-4FCB-B88A-3737B38F60DFQ33930536-676FF84B-03EC-4BB1-B386-604714013000Q33975559-AB3FD757-7A58-40C9-9CAA-ADC7FA20816FQ34238722-6F8A9639-A6B3-448D-A2B6-73FFF2CDE511Q34337159-DBEA191D-933C-4323-82AD-942852FE691CQ34374437-489A2B8F-965D-4C3F-A7D5-FBAD1C45C4CEQ34613063-1403DB80-2D30-4855-AE27-60BB7DB5C9D9Q35002122-5DD7C75F-7278-444B-B837-9FBAD660B40EQ36749836-48D9BB44-5F8F-4689-BA4B-9F1636121D99Q37290664-35EAEA3E-644C-4F5C-A208-06F37533439EQ37483986-80D9DD82-1DCA-4C2D-8CBD-B4517C01CC43Q37487739-AA429BBC-48AC-4D78-AEBC-DA4E8AFE5D29Q37768341-9F94C02F-CC5E-45AB-98FA-360BDE908C3EQ38058370-0E4DE5F0-3C28-4D9C-935E-7EB3674391F4Q39340736-C67B47D5-B8D3-4612-BA1F-5FEF606DB578Q39516179-67E9BCE8-5969-4F4E-B096-9B92FD30A08AQ42431184-FB3ECF56-757E-4A4E-A0E4-D62BAA587D35Q45292523-3FE33BBA-8AA1-47D2-9BC4-186D224DC415Q48299692-D555D4E5-690C-4BA0-A05D-04BBA7E6981EQ48465873-193CF5A4-EC14-47F2-829B-8AE2CF6973B1Q55268687-E1515C7B-D1B3-410E-BAF4-238637974D08
P2860
S100B and response to treatment in major depression: a pilot study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
S100B and response to treatment in major depression: a pilot study.
@en
S100B and response to treatment in major depression: a pilot study.
@nl
type
label
S100B and response to treatment in major depression: a pilot study.
@en
S100B and response to treatment in major depression: a pilot study.
@nl
prefLabel
S100B and response to treatment in major depression: a pilot study.
@en
S100B and response to treatment in major depression: a pilot study.
@nl
P2093
P1476
S100B and response to treatment in major depression: a pilot study.
@en
P2093
Holger Kirchner
Marion Peters
Martin Wiesmann
Matthias Rothermundt
Sebastian Rudolf
Ulrich Missler
Volker Arolt
P304
P356
10.1016/S0924-977X(03)00016-6
P407
P577
2003-08-01T00:00:00Z